Skip to content

Celecoxib USP Related Compound C

Celecoxib USP Related Compound C

Product Description
CAT No.
ALN-C005028
CAS No.
170570-09-9
Mol. F.
C18H16F3N3O2S
Mol. Wt.
395.4
Stock
Please Inquire
RFQ
Chemical Name : 4-(5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
Smiles : CC(C=C(C)C=C1)=C1C2=CC(C(F)(F)F)=NN2C3=CC=C([S](N)(=O)=O)C=C3
Inchi : InChI=1S/C16H25N7O5/c1-8(2)10(17)13(24)20-9(3)15(26)28-5-4-27-7-23-6-19-11-12(23)21-16(18)22-14(11)25/h6,8-10H,4-5,7,17H2,1-3H3,(H,20,24)(H3,18,21,22,25)/t9-,10?/m0/s1

Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles

Tim Tome, Zdenko u010casar ,OrcID andAleu0161 ObrezanMolecules 2020, 25(4), 809

A selective and sensitive LC-MS/MS method for the simultaneous determination of twopotential genotoxic impurities in celecoxib

Ambavaram Vijaya Bhaskar Reddy, Nandigam Venugopal & Gajulapalle Madhavi – Journal of Analytical Science and Technology volume 5, Article number: 18 (2014)

Stability-Indicating HPLC Method for Quantification of Celecoxib and Diacerein Along With Its Impurities in Capsule Dosage Form

Hanimi Reddy Bapatu, Ravi Kumar Maram, R. Satyanarayana Murthy – Journal of Chromatographic Science, Volume 53, Issue 1, January 2015, Pages 144–153

Request For Quotation

Related Products